Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs …

STEVEN HYMAN (Chair), The Broad Institute of Massachusetts Institute of Technology and Harvard University STORY LANDIS (Vice Chair), Former Director, National Institute of Neurological Disorders and Stroke SUSAN AMARA, Society for Neuroscience STEPHEN BRANNAN, Takeda Pharmaceuticals International, Inc. KATJA BROSE, Cell Press DANIEL BURCH, Pharmaceutical Product Development, LLC SARAH CADDICK, Gatsby Charitable Foundation ROSA CANET-AVILES, Foundation for the National Institutes of Health MARIA CARRILLO, Alzheimer’s Association C. THOMAS CASKEY, Baylor College of Medicine KAREN CHANDROSS, Sanofi US TIMOTHY COETZEE, National Multiple Sclerosis Society FAY LOMAX COOK, National Science Foundation WILLIAM DUNN, Food and Drug Administration EMMELINE EDWARDS, National Center for Complementary and Integrative Medicine MARTHA FARAH, University of Pennsylvania DANIEL GESCHWIND, University of California, Los Angeles HANK GREELY, Stanford University MAGALI HAAS, Orion Bionetworks RAMONA HICKS, One Mind for Research…


Link to Full Article: Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs …